Distinct representation of muscle weakness in QMG and MG-ADL

Lancet Neurol. 2018 Mar;17(3):204-205. doi: 10.1016/S1474-4422(18)30037-1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Activities of Daily Living*
  • Antibodies, Monoclonal, Humanized
  • Double-Blind Method
  • Humans
  • Muscle Weakness*
  • Myasthenia Gravis
  • Receptors, Cholinergic

Substances

  • Antibodies, Monoclonal, Humanized
  • Receptors, Cholinergic
  • eculizumab